Genmab — Juni 2018
-
Godmorgen....vi kan vel sammenfatte det til at når det går godt for Genmab(dara) så hjælper det også for de patienter som lider af denne forbandede sygdom.
-
-
Godt nok en sløv volume der er på i dag
-
Der kan man da snakke om ikke at se hullerne i osten
-
puha - vi skal 3 år tilbage for at finde warrants, der er værd at tale om...
-
Det kan ikke være nemt at tiltrække eller fastholde talent, når aktieaflønningen halter så voldsomt
-
yes, i am sure you are correct. - but perhaps not this afternoon,
as genmabbers are cellebrating their new home https://twitter.com/search?f=tweets&vertical=default&q=genmab OR daratumumab OR darzalex OR ofatumumab&src=savs https://twitter.com/adviesbureauDWA/status/1012345978802835456 -
ro på - det bliver ikke hyret kernekompetencer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind